Newsroom

Emmes is excited to share the significant progress being made in clinical studies.

 We also give you a look inside some of our own news.

 

 

Emmes Newsroom
Company News
Emmes Announces its Contribution to Second Remdesivir Clinical Trial for COVID-19

Read more Download

Emmes Newsroom
Company News
Emmes Employees Co-Author COVID-19 Vaccine Report for the New England Journal of Medicine

Read more Download

Emmes Newsroom
Company News
Life sciences firm’s new CEO talks expansion plans during Covid-19 pandemic

Read more Download

Emmes Newsroom
Company News
Emmes Selected as Corporate Achievement Award Winner by the Montgomery County Chamber of Commerce

Read more Download

Emmes Newsroom
Company News
The Washington Post Announces Top Workplace Rankings

Read more Download

Emmes Newsroom
Company News
Dr. Christine Dingivan Joins Emmes as President and CEO

Read more Download

Emmes Newsroom
Company News
Emmes Announces its Role in Phase 1 COVID-19 Vaccine Trial

Read more Download

Emmes Newsroom
Company News
Emmes Chosen as a Top Area Workplace

Read more Download

Emmes Newsroom
Company News
Emmes Announces Its Work on a Phase 3 Clinical Trial for Breakthrough Therapy Designation Product

Read more Download

Emmes Newsroom
Company News
Emmes Announces its Contribution to NIH ACTT Clinical Trial for Remdesivir

Read more Download